Distinct roles for interleukin-23 receptor signaling in regulatory T cells in sporadic and inflammation-associated carcinogenesis.

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by pilot grants from the Vanderbilt Digestive Disease Research Center Grant (P30DK058404) and Vanderbilt Institute for Infection, Immunology, & Inflammation (to JG). The National Institute of Diabetes and Digestive and Kidney Diseases (R03DK123489) and Vanderbilt-Ingram Cancer Center GI SPORE (P50CA236733) (to JG). The Academy Ter Meulen Grant from the Royal Netherlands Academy of Arts and Sciences and the Cultural Foundation Grant from the Cultural Foundation (to JJ). T32GM00734, to the VU Medical Scientist Training Program.US Department of Veterans Affairs Office of Medical Research (IK2BX004648, to YC and I01BX001426, to CW)."